Low-Cost, Isotope-Free Sentinel Node Mapping with Methylene Blue and Fluorescein in Patients with Early Breast Cancer: Experience from an Indian Tertiary Care Centre
Abstract: Purpose: Sentinel lymph node biopsy (SLNB) is out of reach in many Indian hospitals, which have neither a radioisotope facility nor a near-infrared camera. We describe our experience with an inexpensive method that needs neither: methylene blue and fluorescein sodium injected together. Methods: Forty women with breast cancer and clinically normal axillary nodes were studied. After general anaesthesia was induced, 2 mL of 1% methylene blue and 2 mL of 20% fluorescein sodium were injected around the areola. The surgeon searched for nodes by sight and under a simple ultraviolet lamp. We noted how often a node was found, what each dye contributed, how long each took to show, whether results differed between the first and second halves of the series, how many patients needed axillary clearance, complications, and the surgeon's rating of ease. Results: A sentinel node was found in 36 of 40 patients (90.0%; 95% CI 76.9-96.0%). Fluorescein located a node in 35 of these 36 patients and methylene blue in 25. The success rate was 18/20 in both the first and the last 20 patients. Methylene blue became visible at a mean of 24.8 minutes and fluorescein at 33.8 minutes. Thirty-two patients (80.0%) were spared axillary clearance. One patient had minor skin necrosis. Surgeons scored ease of use at 4.05 ? 0.50 out of 5. Conclusion: Two cheap dyes and a simple lamp were enough to find the sentinel node in nine of ten patients, and the technique was easy to take up. It is a realistic choice for centres without nuclear medicine or near-infrared imaging. Cost analysis and a head-to-head comparison with the standard method are still required.
Keywords: Sentinel lymph node biopsy, Breast cancer, Methylene blue, Fluorescein sodium, Low-cost technique, India
How to Cite?: Doon MK, Gora BS, Sharma VK, "Low-Cost, Isotope-Free Sentinel Node Mapping with Methylene Blue and Fluorescein in Patients with Early Breast Cancer: Experience from an Indian Tertiary Care Centre", Volume 15 Issue 11, November 2026, International Journal of Science and Research (IJSR), Pages: 669-672, https://www.ijsr.net/getabstract.php?paperid=MR261115173213, DOI: https://dx.doi.org/10.21275/MR261115173213